MS drug Lemtrada investigators protest FDA decision

A board to discuss the soon-to-be released drug Campath as a treatment for Multiple Sclerosis
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

MS drug Lemtrada investigators protest FDA decision

Post by MSUK »

Several multiple sclerosis (MS) experts who were involved in the clinical development program for alemtuzumab (Lemtrada, Genzyme) have voiced their disappointment and frustration over the recent decision by the US Food and Drug Administration (FDA) not to approve the drug.

Stephen Krieger, MD, from Mount Sinai Medical Center, New York; Edward Fox, MD, from the Multiple Sclerosis Clinic of Central Texas, Round Rock; and Jeffrey Cohen, MD, from Cleveland Clinic, Ohio, all told Medscape Medical News that they strongly disagree with the FDA decision and are worried about the consequences, which could include patients sourcing the drug from other countries but not being monitored for the serious safety issues.... Read More - http://www.ms-uk.org/index.cfm/lemtrada
MS-UK - http://www.ms-uk.org/
ChrisDeMuthJr
Newbie
Posts: 2
Joined: Fri Jan 17, 2014 5:41 am

Re: MS drug Lemtrada investigators protest FDA decision

Post by ChrisDeMuthJr »

The FDA Nixes a Pathbreaking Drug for MS: http://online.wsj.com/news/articles/SB1 ... #printMode
Post Reply
  • Similar Topics
    Replies
    Views
    Last post

Return to “Campath (Lemtrada, Alemtuzumab)”